拓普康
7732
Temona
3985
Forside
2330
岡本硝子
7746
Delta-Fly Pharma
4598
(Q2)2024/04/30 | (Q1)2024/01/31 | (FY)2023/10/31 | (Q4)2023/10/31 | (Q3)2023/07/31 | (Q2)2023/04/30 | (Q1)2023/01/31 | (FY)2022/10/31 | (Q4)2022/10/31 | (Q3)2022/07/31 | |
---|---|---|---|---|---|---|---|---|---|---|
營業總收入 | -10.13%27.73億 | -8.21%26.39億 | 3.63%118.87億 | -3.07%31.3億 | 5.86%27.98億 | 1.95%30.86億 | 11.71%28.75億 | -15.98%114.71億 | 9.88%32.28億 | -23.74%26.43億 |
主營業務成本 | 1.13%25.43億 | -0.95%22.49億 | 4.16%100.19億 | -1.85%28.61億 | 9.33%23.73億 | 1.13%25.14億 | 10.94%22.71億 | -20.48%96.19億 | 11.43%29.15億 | -28.52%21.71億 |
毛利 | -59.66%2.3億 | -35.50%3.9億 | 0.85%18.68億 | -14.39%2.69億 | -10.08%4.24億 | 5.72%5.71億 | 14.72%6.04億 | 18.97%18.52億 | -2.73%3.14億 | 10.18%4.72億 |
營業費用 | -6.33%3.05億 | -5.26%3.09億 | 10.22%13.14億 | 5.73%3.46億 | 11.95%3.17億 | 16.07%3.25億 | 8.03%3.27億 | 3.69%11.92億 | 8.51%3.27億 | -4.66%2.83億 |
營業利潤 | -130.25%-7,436.9萬 | -71.07%8,026.6萬 | -16.08%5.54億 | -475.65%-7,731萬 | -43.00%1.08億 | -5.44%2.46億 | 23.75%2.77億 | 62.12%6.6億 | -163.89%-1,343萬 | 43.60%1.89億 |
營業外利息收入與支出淨額 | -278.06%-194.7萬 | -170.74%-101.8萬 | -139.32%-219.7萬 | -187.79%-75.4萬 | -112.31%-55.2萬 | -166.84%-51.5萬 | -85.22%-37.6萬 | -51.74%-91.8萬 | -49.71%-26.2萬 | -48.57%-26萬 |
營業外利息支出 | 278.06%194.7萬 | 170.74%101.8萬 | 139.32%219.7萬 | 187.79%75.4萬 | 112.31%55.2萬 | 166.84%51.5萬 | 85.22%37.6萬 | 51.74%91.8萬 | 49.71%26.2萬 | 48.57%26萬 |
投資淨收益 | 0 | 23.10%2,457.9萬 | 16.84%4,634萬 | 0 | 12.67%2,637.3萬 | 0 | 22.84%1,996.7萬 | 40.14%3,966.2萬 | 0 | 45.81%2,340.7萬 |
被指定為現金流套期的金融工具損益 | ||||||||||
終止確認可供出售金融資產損益 | ||||||||||
聯營企業及其他參股權益產生的收益 | -43.29%1,228.4萬 | 3.26%1,668.6萬 | 371.10%8,497.5萬 | 2,708.14%1,890.9萬 | 244.59%2,824.6萬 | 387.93%2,166.1萬 | 553.65%1,615.9萬 | -214.32%-3,134.5萬 | 96.22%-72.5萬 | -234.77%-1,953.5萬 |
特殊收入(費用) | -18.70%1,331萬 | -14.67%1,086.8萬 | -9.43%5,414萬 | -7.55%1,276.1萬 | -20.64%1,227萬 | -4.65%1,637.2萬 | -4.53%1,273.7萬 | 434.38%5,977.7萬 | 123.34%1,380.3萬 | 32.33%1,546.2萬 |
減:其他特殊費用 | 18.70%-1,331萬 | 14.67%-1,086.8萬 | 9.43%-5,414萬 | 7.55%-1,276.1萬 | 20.64%-1,227萬 | 4.65%-1,637.2萬 | 4.53%-1,273.7萬 | -11.95%-5,977.7萬 | -13.81%-1,380.3萬 | -32.33%-1,546.2萬 |
其他營業外收入(費用) | -63.91%717.1萬 | -59.03%986.7萬 | -28.71%5,833.1萬 | -36.34%1,049.3萬 | -79.68%388.2萬 | -22.43%1,987萬 | 16.76%2,408.6萬 | -10.34%8,182.7萬 | -20.80%1,648.3萬 | 0.23%1,910萬 |
稅前利潤 | -114.36%-4,355.3萬 | -59.65%1.41億 | -1.67%7.95億 | -326.25%-3,590.3萬 | -21.69%1.78億 | 2.77%3.03億 | 29.32%3.5億 | 51.04%8.09億 | 143.28%1,586.9萬 | 17.89%2.27億 |
所得稅 | -83.09%1,729.2萬 | -53.43%5,466萬 | 5.80%3.14億 | 104.12%4,136.6萬 | -32.99%5,312.5萬 | -8.33%1.02億 | 36.78%1.17億 | 27.90%2.97億 | -52.51%2,026.6萬 | 26.83%7,928.3萬 |
除稅後利潤 | -130.28%-6,084.5萬 | -62.78%8,659萬 | -6.01%4.81億 | -1,657.31%-7,726.9萬 | -15.64%1.25億 | 9.52%2.01億 | 25.86%2.33億 | 68.75%5.12億 | 94.46%-439.7萬 | 13.61%1.48億 |
持續經營利潤 | -130.28%-6,084.5萬 | -62.78%8,659.1萬 | -6.01%4.81億 | -1,657.31%-7,726.9萬 | -15.64%1.25億 | 9.52%2.01億 | 25.86%2.33億 | 68.75%5.12億 | 94.46%-439.7萬 | 13.61%1.48億 |
歸屬于少數股東的淨利潤 | ||||||||||
歸屬於母公司的淨利潤 | -130.28%-6,084.5萬 | -62.78%8,659萬 | -6.01%4.81億 | -1,657.31%-7,726.9萬 | -15.64%1.25億 | 9.52%2.01億 | 25.86%2.33億 | 68.75%5.12億 | 94.46%-439.7萬 | 13.61%1.48億 |
優先股派息 | ||||||||||
其他優先股派息 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
歸屬于普通股股東的淨利潤 | -130.28%-6,084.5萬 | -62.78%8,659萬 | -6.01%4.81億 | -1,657.31%-7,726.9萬 | -15.64%1.25億 | 9.52%2.01億 | 25.86%2.33億 | 68.75%5.12億 | 94.46%-439.7萬 | 13.61%1.48億 |
總派息金額 | ||||||||||
基本每股收益 | -130.27%-20.62 | -62.78%29.35 | -6.00%163.14 | -1,657.72%-26.19 | -15.62%42.35 | 9.54%68.12 | 25.85%78.86 | 68.76%173.55 | 94.46%-1.49 | 13.60%50.19 |
稀釋每股收益 | -130.28%-20.6247 | -62.78%29.35 | -6.00%163.14 | -1,657.36%-26.1908 | -15.63%42.3443 | 9.53%68.1171 | 25.85%78.86 | 68.76%173.55 | 94.46%-1.4903 | 13.62%50.19 |
每股派息 | -50.00%10 | 0 | 12.50%45 | 25.00%25 | 0 | 0.00%20 | 0 | 0.00%40 | 0.00%20 | 0 |
貨幣單位 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 |
會計準則 | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |